Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG?: Comparison with planar scintigraphy and SPECT in pheochromocytoma

Clinical Nuclear Medicine

Volumn 38, Issue 9, 2013, Pages

  Sharma, Punit ^a   Dhull, Varun Singh ^a   Jeph, Sunil ^a   Reddy, Rama Mohan ^a   Singh, Harmandeep ^a   Naswa, Niraj ^a   Bal, Chandrasekhar ^a   Kumar, Rakesh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

131I MIBG; pheochromocytoma; planar scintigraphy; SPECT; SPECT CT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131;

ADRENAL GLAND; ADULT; ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; PREDICTIVE VALUE; RADIATION EXPOSURE; RETROSPECTIVE STUDY; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84883455263     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318279bcb2     Document Type: Article

References (21)

1. Pacak K, Linehan WM, Eisenhofer G, et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001;134:315Y329.
2. Sinclair AM, Isles CG, Brown I, et al. Secondary hypertension in a blood pressure clinic. Arch Intern Med. 1987;147:1289Y1293.
3. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287:1427Y1434.
4. Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab. 2004; 89:479Y491.
5. Shapiro B, Copp JE, Sisson JC, et al. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med. 1985;26:576Y585.
6. Bomanji J, Levison DA, Flatman WD, et al Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison. J Nucl Med. 1987;28:973Y978.
7. Shapiro B, Gross MD. Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG. Med Pediatr Oncol. 1987;15:170Y177.
8. ICRP. Radiation dose to patients from radiopharmaceuticals (Addendum 3 to ICRP publication 53). ICRP publication 106 approved by the commission in October 2007. Ann ICRP. 2008;38:1Y197.
9. Sharma P, Singh H, Kumar R, et al. Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management. Nucl Med Commun. 2012;33:139Y147.
10. Sharma P, Kumar R, Das KJ, et al. Detection and localization of post-operative and post-traumatic bile leak: hybrid SPECT-CT with 99mTc-Mebrofenin. Abdom Imaging. 2012;37:801Y811.
11. Ciappuccini R, Morera J, Pascal P, et al. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience. Clin Nucl Med. 2012;37:223Y228.
12. Rozovsky K, Koplewitz BZ, Krausz Y, et al. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma. AJR Am J Roentgenol. 2008;190:1085Y1890.
13. Meyer-Rochow GY, Schembri GP, Benn DE, et al. The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma. Ann Surg Oncol. 2010;17:392Y400.
14. Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8:283Y298.
15. Svanholm H, Starklint H, Gundersen HJ, et al. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. APMIS. 1989;97:689Y698.
16. Guilloteau D, Chalon S, Baulieu JL, et al. Comparison of MIBG and monoamines uptake mechanisms: pharmacological animal and blood platelets studies. Eur J Nucl Med. 1988;14:341Y344.
17. Fukuoka M, Taki J, Mochizuki T, et al. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/ paraganglioma and neuroblastoma. Clin Nucl Med. 2011;36:1Y7.
18. Kizu H, Takayama T, Tsushima H, et al. Localization of metastases from malignant pheochromocytoma in patients undergoing 131I-MIBG therapy with manually fused 123I-MIBGSPECTand CTimages.J Nucl MedTechnol. 2008;36:186Y188.
19. Gross MD, Gauger PG, Djekidel M, et al. The role of PET in the surgical approach to adrenal disease. Eur J Surg Oncol. 2009;35:1137Y1145.
20. NaswaN, Sharma P,NazarAH, et al. Prospective evaluation of 68Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study. Eur Radiol. 2012;22:710Y719.
21. Bombardieri E, Giammarile F, Aktolun C. 131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010;37:2436Y2446.